Image Source: ET Manufacturing
Hexaware Technologies Ltd has announced a strategic partnership with Abluva to codevelop secure Agentic AI solutions tailored for the life sciences industry, marking a significant step in AIdriven healthcare transformation.
Key Highlights
-
The collaboration aims to enhance data privacy, regulatory compliance, and operational efficiency across pharmaceutical and biotech workflows.
-
Agentic AI, a nextgen framework, enables autonomous decisionmaking while maintaining strict governance and traceability—critical for clinical trials and drug development.
-
Hexaware will integrate its proprietary automation platform Tensai® and cloudnative Amaze® technology to accelerate deployment and scalability.
Strategic Impact
-
The partnership is expected to streamline R&D pipelines, reduce timetomarket for therapies, and improve patient outcomes through intelligent data modeling.
-
Abluva brings deep domain expertise in biomedical informatics and secure AI architecture, complementing Hexaware’s enterprise IT capabilities.
Outlook
This alliance positions both firms at the forefront of ethical AI innovation in life sciences, with global expansion plans already underway.
Sources: Hexaware Technologies Press Release, Rediff Money, Economic Times, Hexaware Newsroom, BusinessWorld India
Advertisement
Advertisement